Literature DB >> 11548945

Optimization of Gamma knife treatment planning via guided evolutionary simulated annealing.

P Zhang1, D Dean, A Metzger, C Sibata.   

Abstract

We present a method for generating optimized Gamma Knife (Elekta, Stockholm, Sweden) radiosurgery treatment plans. This semiautomatic method produces a highly conformal shot packing plan for the irradiation of an intracranial tumor. We simulate optimal treatment planning criteria with a probability function that is linked to every voxel in a volumetric (MR or CT) region of interest. This sigmoidal P+ parameter models the requirement of conformality (i.e., tumor ablation and normal tissue sparing). After determination of initial radiosurgery treatment parameters, a guided evolutionary simulated annealing (GESA) algorithm is used to find the optimal size, position, and weight for each shot. The three-dimensional GESA algorithm searches the shot parameter space more thoroughly than is possible during manual shot packing and provides one plan that is suitable to the treatment criteria of the attending neurosurgeon and radiation oncologist. The result is a more conformal plan, which also reduces redundancy, and saves treatment administration time.

Entities:  

Mesh:

Year:  2001        PMID: 11548945     DOI: 10.1118/1.1386427

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  2 in total

1.  Incorporate imaging characteristics into an arteriovenous malformation radiosurgery plan evaluation model.

Authors:  Pengpeng Zhang; Leester Wu; Tian Liu; Gerald J Kutcher; Steven Isaacson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-01       Impact factor: 7.038

2.  MAGAT gel and EBT2 film-based dosimetry for evaluating source plugging-based treatment plan in Gamma Knife stereotactic radiosurgery.

Authors:  Gopishankar Natanasabapathi; Vivekanandhan Subbiah; Shashank Sharad Kale; Goura Kishor Rath; S Senthilkumaran; Sanjay Thulkar; Vellaiyan Subramani; M A Laviraj; Raj Kishor Bisht; A K Mahapatra
Journal:  J Appl Clin Med Phys       Date:  2012-11-08       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.